CN100355788C - 活化胶原蛋白支架材料及其专用融合活性修复因子 - Google Patents
活化胶原蛋白支架材料及其专用融合活性修复因子 Download PDFInfo
- Publication number
- CN100355788C CN100355788C CNB2005101327929A CN200510132792A CN100355788C CN 100355788 C CN100355788 C CN 100355788C CN B2005101327929 A CNB2005101327929 A CN B2005101327929A CN 200510132792 A CN200510132792 A CN 200510132792A CN 100355788 C CN100355788 C CN 100355788C
- Authority
- CN
- China
- Prior art keywords
- collagen
- activity
- fusion
- special
- reparative factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010035532 Collagen Proteins 0.000 title claims abstract description 52
- 102000008186 Collagen Human genes 0.000 title claims abstract description 52
- 239000000463 material Substances 0.000 title claims abstract description 25
- 230000004927 fusion Effects 0.000 claims abstract description 50
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims description 53
- 230000004913 activation Effects 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 abstract description 35
- 102000004169 proteins and genes Human genes 0.000 abstract description 14
- 238000002360 preparation method Methods 0.000 abstract description 11
- 108091036078 conserved sequence Proteins 0.000 abstract description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 30
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 30
- 210000000988 bone and bone Anatomy 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 11
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical group SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 8
- 230000008439 repair process Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000008733 trauma Effects 0.000 description 7
- 102000012422 Collagen Type I Human genes 0.000 description 6
- 108010022452 Collagen Type I Proteins 0.000 description 6
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000004153 renaturation Methods 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 101000688200 Prevotella intermedia Alkaline phosphatase Proteins 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000009465 prokaryotic expression Effects 0.000 description 4
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 101000762375 Homo sapiens Bone morphogenetic protein 3 Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- -1 PDGF Proteins 0.000 description 2
- 206010061363 Skeletal injury Diseases 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 230000001582 osteoblastic effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 101150061927 BMP2 gene Proteins 0.000 description 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
- 108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000016216 Choristoma Diseases 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 206010060766 Heteroplasia Diseases 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 102000045896 human BMP2 Human genes 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 108010023714 recombinant human bone morphogenetic protein-2 Proteins 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 102220004457 rs11567847 Human genes 0.000 description 1
- 102220023258 rs387907548 Human genes 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (4)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101327929A CN100355788C (zh) | 2005-12-26 | 2005-12-26 | 活化胶原蛋白支架材料及其专用融合活性修复因子 |
US12/159,369 US8802396B2 (en) | 2005-12-26 | 2006-12-01 | Activated collagen scaffold materials and their special fused active restoration factors |
PCT/CN2006/003244 WO2007073661A1 (fr) | 2005-12-26 | 2006-12-01 | Matieres de squelette de collagene activees et leurs facteurs speciaux de restauration active fusionnee |
AT06817938T ATE514712T1 (de) | 2005-12-26 | 2006-12-01 | Aktivierte collagen-gerüstmaterialien und ihre speziellen kondensierten aktiven restorationsfaktoren |
EP06817938A EP1970382B1 (en) | 2005-12-26 | 2006-12-01 | Activated collagen scaffold materials and their special fused active restoration factors |
US14/320,191 US9365617B2 (en) | 2005-12-26 | 2014-06-30 | Activated collagen scaffold materials and their special fused active restoration factors |
US14/320,105 US9359403B2 (en) | 2005-12-26 | 2014-06-30 | Activated collagen scaffold materials and their special fused active restoration factors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101327929A CN100355788C (zh) | 2005-12-26 | 2005-12-26 | 活化胶原蛋白支架材料及其专用融合活性修复因子 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1807459A CN1807459A (zh) | 2006-07-26 |
CN100355788C true CN100355788C (zh) | 2007-12-19 |
Family
ID=36839570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101327929A Active CN100355788C (zh) | 2005-12-26 | 2005-12-26 | 活化胶原蛋白支架材料及其专用融合活性修复因子 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100355788C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8802396B2 (en) * | 2005-12-26 | 2014-08-12 | Yantai Zhenghai Bio-Technology Co., Ltd. | Activated collagen scaffold materials and their special fused active restoration factors |
CN101671396B (zh) * | 2008-09-11 | 2012-07-18 | 烟台正海生物技术有限公司 | 与胶原蛋白特异结合的血管内皮生长因子及其应用 |
CN105601723B (zh) * | 2015-06-11 | 2019-08-09 | 北京奥斯特赛医学科技有限公司 | 一种煅烧骨靶向结合多肽及其合成方法与应用 |
CN110183536B (zh) * | 2018-02-22 | 2021-01-15 | 中国科学院遗传与发育生物学研究所 | 一种复合支架材料及其应用 |
CN111494712B (zh) * | 2020-05-12 | 2021-04-09 | 尧舜泽生物医药(南京)有限公司 | 一种融合有nt3的丝素蛋白神经移植物的制备方法 |
-
2005
- 2005-12-26 CN CNB2005101327929A patent/CN100355788C/zh active Active
Non-Patent Citations (2)
Title |
---|
vWF的结构与功能 钱丽清等.生物化学与生物物理进展,第21卷 1994 * |
骨形态发生蛋白载体材料的研究和应用现状 孙明林等.国外医学生物学工程分册,第24卷第3期 2001 * |
Also Published As
Publication number | Publication date |
---|---|
CN1807459A (zh) | 2006-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU614908B2 (en) | Injectable composition for inductive bone repair | |
US9359403B2 (en) | Activated collagen scaffold materials and their special fused active restoration factors | |
Yoshida et al. | Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study | |
US5106626A (en) | Osteogenic factors | |
KR100259827B1 (ko) | 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법 | |
Kübler et al. | Inductive properties of recombinant human BMP-2 produced in a bacterial expression system | |
CN1951964B (zh) | 长链型重组人骨形态发生蛋白-2及其制备方法和应用 | |
US20070244050A1 (en) | Peptides as solubilizing excipients for transforming growth factor beta proteins | |
CN100355788C (zh) | 活化胶原蛋白支架材料及其专用融合活性修复因子 | |
Han et al. | Collagen‐targeted BMP3 fusion proteins arrayed on collagen matrices or porous ceramics impregnated with Type I collagen enhance osteogenesis in a rat cranial defect model | |
CN101273057B (zh) | 骨形态发生蛋白2活性肽及制备方法和应用 | |
EP0704532A2 (en) | Recombinant chimeric proteins and methods of use thereof | |
Hänseler et al. | Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2 | |
CN100355787C (zh) | 活化的胶原骨修复材料及其专用融合活性骨修复因子 | |
WO2017146819A1 (en) | Implantable drug delivery systems | |
US7892532B2 (en) | Intracellular delivery of osteoinductive proteins and peptides | |
US20060093640A1 (en) | Osteoinductive biomaterials | |
CN101003802A (zh) | 人骨形态发生蛋白-2成熟肽的制备方法 | |
NZ248446A (en) | Bone growth composition containing transforming growth factor beta (tgf-beta) and demineralised bone | |
AU2004317501B2 (en) | Intracellular delivery of osteoinductive proteins and peptides | |
Jortikka et al. | Use of myoblasts in assaying the osteoinductivity of bone morphogenetic proteins | |
CN1333295A (zh) | 一种重组人骨形成蛋白-2截短突变体及其制备方法 | |
Mohangi et al. | Enhanced activity of demineralised bone matrix augmented with xenogeneic bone morphogenetic protein complex in rats | |
CA2517496A1 (en) | Intracellular delivery of osteoinductive proteins and peptides | |
ZA200500427B (en) | Osteoinductive biomaterials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: YANTAI ZHENGHAI BIO-TECH CO., LTD. Free format text: FORMER NAME: ZHENGHAI BIOLOGICAL TECHNOLOGY CO., LTD., YANTAI |
|
CP01 | Change in the name or title of a patent holder |
Address after: 264006 No. 10, Yantai economic and Technological Development Zone, Shandong, Hengshan Road Patentee after: YANTAI ZHENGHAI BIO-TECH CO., LTD. Patentee after: Inst. of Genetics & Development Biology, Chinese Academy of Sciences Address before: 264006 No. 10, Yantai economic and Technological Development Zone, Shandong, Hengshan Road Patentee before: Zhenghai Biological Technology Co., Ltd., Yantai Patentee before: Inst. of Genetics & Development Biology, Chinese Academy of Sciences |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 264006 No.7 Nanjing Street, Yantai Economic and Technological Development Zone, Yantai City, Shandong Province Patentee after: YANTAI ZHENGHAI BIO-TECH Co.,Ltd. Patentee after: INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES Address before: 264006 No. 10, Yantai economic and Technological Development Zone, Shandong, Hengshan Road Patentee before: YANTAI ZHENGHAI BIO-TECH Co.,Ltd. Patentee before: INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES |